Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8108451 | 0.81 | HTT (0.49) | USP2POLBLMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL8108405 | 0.81 | HTT (0.49) | USP2POLBLMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL8094760 | 0.81 | HTT (0.49) | USP2POLBLMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL8521958 | 0.81 | EPHX2 (0.39) | EPHX2USP2 | |
| SCHEMBL8102667 | 0.80 | EPHX2 (0.41) | EPHX2USP2SIGMAR1POLBLMNA | |
| SCHEMBL8102633 | 0.80 | TRPV1 (0.49) | EPHX2POLBLMNAL3MBTL1ALDH1A1 | |
| SCHEMBL8102560 | 0.79 | HMOX1 (0.40) | SIGMAR1POLBL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL8102574 | 0.77 | HDAC3 (0.40) | EPHX2LMNASMN1; SMN2KMT2A | |
| SCHEMBL8104122 | 0.76 | MAPT (0.43) | — | |
| SCHEMBL8104210 | 0.76 | MAPT (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6071899-A | Azetidinone derivatives for the treatment of atherosclerosis | SMITHKLINE BEECHAM P.L.C. (GB) | 2000-06-06 | — | — | US | claimed |
| EP-0788478-A1 | AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM PLC (GB) | 1997-08-13 | — | — | EP | claimed |
| WO-1996013484-A1 | AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM PLC (GB) | 1996-05-09 | — | — | WO | claimed |
| US-6071899-A | Azetidinone derivatives for the treatment of atherosclerosis | SMITHKLINE BEECHAM P.L.C. (GB) | 2000-06-06 | — | — | US | disclosed |